Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Hinterberger

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|November 25, 2017
Epitope-Specific Tolerance Modes Differentially Specify Susceptibility to Proteolipid Protein-Induced Experimental Autoimmune EncephalomyelitisLei Wang, Julia Winnewisser, Christine Federle, et al.
Immunology|December 28, 2017
CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient miceBarbara Bathke, Juliane Pätzold, Ronny Kassub, et al.
Development (Cambridge, England)|March 26, 2016
Retrotransposon derepression leads to activation of the unfolded protein response and apoptosis in pro-B cellsAlessandra Pasquarella, Anja Ebert, Gustavo Pereira de Almeida, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2019
Inventories of naive and tolerant mouse CD4 T cell repertoires reveal a hierarchy of deleted and diverted T cell receptorsTobias Hassler, Emanuel Urmann, Sebastian Teschner, et al.
Immunity|June 14, 2015
Thymic B Cells Are Licensed to Present Self Antigens for Central T Cell Tolerance InductionTomoyoshi Yamano, Jelena Nedjic, Maria Hinterberger, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memoryMaria Hinterberger, Raphael Giessel, Giovanna Fiore, et al.
Nature Communications|November 8, 2019
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodiesJosé Medina-Echeverz, Maria Hinterberger, Marco Testori, et al.
Scientific Reports|March 30, 2023
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradicationMaria Hinterberger, Kathrin Endt, Barbara Bathke, et al.
Frontiers in Immunology|February 23, 2026
MVA-Spike encoding the A subunit of dmLT safely enhances systemic and mucosal immune responsesStephan Rambichler, Ronny Kassub, Rodrigo Carrasco-León, et al.
Oncoimmunology|July 21, 2022
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosisÁngela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|November 25, 2017
Epitope-Specific Tolerance Modes Differentially Specify Susceptibility to Proteolipid Protein-Induced Experimental Autoimmune EncephalomyelitisLei Wang, Julia Winnewisser, Christine Federle, et al.
Immunology|December 28, 2017
CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient miceBarbara Bathke, Juliane Pätzold, Ronny Kassub, et al.
Development (Cambridge, England)|March 26, 2016
Retrotransposon derepression leads to activation of the unfolded protein response and apoptosis in pro-B cellsAlessandra Pasquarella, Anja Ebert, Gustavo Pereira de Almeida, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2019
Inventories of naive and tolerant mouse CD4 T cell repertoires reveal a hierarchy of deleted and diverted T cell receptorsTobias Hassler, Emanuel Urmann, Sebastian Teschner, et al.
Immunity|June 14, 2015
Thymic B Cells Are Licensed to Present Self Antigens for Central T Cell Tolerance InductionTomoyoshi Yamano, Jelena Nedjic, Maria Hinterberger, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memoryMaria Hinterberger, Raphael Giessel, Giovanna Fiore, et al.
Nature Communications|November 8, 2019
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodiesJosé Medina-Echeverz, Maria Hinterberger, Marco Testori, et al.
Scientific Reports|March 30, 2023
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradicationMaria Hinterberger, Kathrin Endt, Barbara Bathke, et al.
Frontiers in Immunology|February 23, 2026
MVA-Spike encoding the A subunit of dmLT safely enhances systemic and mucosal immune responsesStephan Rambichler, Ronny Kassub, Rodrigo Carrasco-León, et al.
Oncoimmunology|July 21, 2022
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosisÁngela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.
Pageof 3